UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Recommendations by the Spanish Society of Hospital Pharmacy, the Spanish Society of Oncology Nursing and the Spanish Society of Medical Oncology for the safe management of antineoplastic medication in cancer patients

Clinical & translational oncology, 2019-04, Vol.21 (4), p.467-478

2019

Volltextzugriff (PDF)

4CPS-252 Optimisation of ertapenem posology in a critically ill patient by therapeutic drug monitoring: a case report

European journal of hospital pharmacy. Science and practice, 2023-03, Vol.30 (Suppl 1), p.A209-A209

2023

Volltextzugriff (PDF)

4CPS-051 Pharmacokinetics alterations in two critically ill patients on extracorporeal membrane oxygenation receiving isavuconazol

European journal of hospital pharmacy. Science and practice, 2022-03, Vol.29 (Suppl 1), p.A44-A45

2022

Volltextzugriff (PDF)

4CPS-163 Early experiences in switching between monoclonal antibodies in chronic migraine preventive therapy

European journal of hospital pharmacy. Science and practice, 2022-03, Vol.29 (Suppl 1), p.A83-A84

2022

Volltextzugriff (PDF)

5PSQ-080 Ertapenem-induced neurotoxicity: role of plasma concentration monitoring

European journal of hospital pharmacy. Science and practice, 2022-03, Vol.29 (Suppl 1), p.A144-A144

2022

Volltextzugriff (PDF)

5PSQ-070 Pharmaceutical care in an onco-haematological clinical trials unit

European journal of hospital pharmacy. Science and practice, 2023-03, Vol.30 (Suppl 1), p.A136-A136

2023

Volltextzugriff (PDF)

4CPS-249 Relationship between renal function and ertapenem plasma concentration in adult patients

European journal of hospital pharmacy. Science and practice, 2023-03, Vol.30 (Suppl 1), p.A105-A106

2023

Volltextzugriff (PDF)

5PSQ-012 Drug interactions and polypharmacy in a cohort of HIV positive haemophiliac patients

European journal of hospital pharmacy. Science and practice, 2020-03, Vol.27 (Suppl 1), p.A155-A155

2020

Volltextzugriff (PDF)

4CPS-038 Intrapleural colistin for pleural empyema caused by extensively drug-resistant Pseudomonas aeruginosa: a case report

European journal of hospital pharmacy. Science and practice, 2022-03, Vol.29 (Suppl 1), p.A39-A40

2022

Volltextzugriff (PDF)

PS-031 Pharmaceutical interventions performed in a short stay emergency service

European journal of hospital pharmacy. Science and practice, 2017-03, Vol.24 (Suppl 1), p.A240-A241

2017

Volltextzugriff (PDF)

4CPS-152 Characterisation of a compounded voriconazole solution for nebulisation and description of its use in the clinical setting

European journal of hospital pharmacy. Science and practice, 2022-03, Vol.29 (Suppl 1), p.A190-A190

2022

Volltextzugriff (PDF)

6ER-021 Evaluation of COVID mortality during hospital admission in patients receiving oncological treatment

European journal of hospital pharmacy. Science and practice, 2022-03, Vol.29 (Suppl 1), p.A174-A174

2022

Volltextzugriff (PDF)

PS-055 BENZODIAZEPINES and Z-DRUGS deprescription by a multidisciplinary pharmacotherapy revision focused on the patient

European journal of hospital pharmacy. Science and practice, 2017-03, Vol.24 (Suppl 1), p.A251-A251

2017

Volltextzugriff (PDF)

5PSQ-124 The role of the clinical pharmacist in avoiding medication errors in a clinical research onco-haematologic unit

European journal of hospital pharmacy. Science and practice, 2022-03, Vol.29 (Suppl 1), p.A157-A158

2022

Volltextzugriff (PDF)

5PSQ-071 Real-world results of effectiveness and security of erenumab and galcanezumab in migraine patients

European journal of hospital pharmacy. Science and practice, 2022-03, Vol.29 (Suppl 1), p.A201-A201

2022

Volltextzugriff (PDF)

4CPS-062 Rituximab pharmacokinetics characterisation in plasma and urine in a patient with nephotic syndrome

European journal of hospital pharmacy. Science and practice, 2022-03, Vol.29 (Suppl 1), p.A184-A184

2022

Volltextzugriff (PDF)

4CPS-126 A population pharmacokinetic model of adalimumab in a cohort of paediatric patients with inflammatory bowel disease: a preliminary analysis

European journal of hospital pharmacy. Science and practice, 2020-03, Vol.27 (Suppl 1), p.A106-A107

2020

Volltextzugriff (PDF)

4CPS-362 Nonagenarians versus non-nonagenarians in the hip fracture patient: from a pharmacotherapeutic point of view

European journal of hospital pharmacy. Science and practice, 2021-03, Vol.28 (Suppl 1), p.A95-A95

2021

Volltextzugriff (PDF)

4CPS-322 Adalimumab concentrations prior to the implementation of therapeutic drug monitoring in patients with inflammatory bowel disease

European journal of hospital pharmacy. Science and practice, 2021-03, Vol.28 (Suppl 1), p.A76-A76

2021

Volltextzugriff (PDF)

CP-182 Pharmaceutical validation of treatments: From the pharmacy or at the hospital wards?

European journal of hospital pharmacy. Science and practice, 2016-03, Vol.23 (Suppl 1), p.A80-A81

2016

Volltextzugriff (PDF)

5PSQ-080 Identification of pharmacological interactions between ivacaftor/tezacaftor/elexacaftor and dietary supplements/herbs in patients with cystic fibrosis in an outpatient pharmaceutical care unit

European journal of hospital pharmacy. Science and practice, 2023-03, Vol.30 (Suppl 1), p.A216-A217

2023

Volltextzugriff (PDF)

5PSQ-095 Comparison between the maximum recommended dose of azathioprine according to the enzymatic activity of thiopurine methyltransferase and 6-thioguanine levels with the maximum tolerated dose

European journal of hospital pharmacy. Science and practice, 2022-03, Vol.29 (Suppl 1), p.A150-A151

2022

Volltextzugriff (PDF)

4CPS-131 Ruxolitinib as salvage therapy in paediatric patients with steroid-refractory graft-versus-host disease

European journal of hospital pharmacy. Science and practice, 2019-03, Vol.26 (Suppl 1), p.A130-A130

2019

Volltextzugriff (PDF)

NP-012 Standardisation of analgesia and sedation infusion solutions in paediatric palliative patients receiving end-of-life care at home

European journal of hospital pharmacy. Science and practice, 2019-03, Vol.26 (Suppl 1), p.A295-A296

2019

Volltextzugriff (PDF)

Efectividad del uso de cefuroxima intracameral como profilaxis en la cirugía de cataratas

Farmacia hospitalaria, 2012-05, Vol.36 (3), p.170-172

2012

Volltextzugriff (PDF)

1 – 25 von 44

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(41)
Mit Volltextzugriff
(35)

Publikationsform

Artikel
(44)

Sprache

Erscheinungsjahr

n.n

Thema

Conflicts Of Interest
(16)
Patients
(15)
Humans
(9)
Aged
(7)
Female
(7)
Male
(7)
Monoclonal Antibodies
(7)
Pharmacists
(7)
Immunotherapy
(5)
Middle Aged
(5)
Adult
(4)
Drug Dosages
(4)
Inflammatory Bowel Disease
(4)
Pharmaceuticals
(4)
Prospective Studies
(4)
Section 4: Clinical Pharmacy Services
(4)
Section 5: Patient Safety And Quality Assurance
(4)
Aged, 80 And Over
(3)
Clinical Trials
(3)
Drug Stores
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Recommendations by the Spanish Society of Hospital Pharmacy, the Spanish Society of Oncology Nursing and the Spanish Society of Medical Oncology for the safe management of antineoplastic medication in cancer patients

4CPS-252 Optimisation of ertapenem posology in a critically ill patient by therapeutic drug monitoring: a case report

4CPS-051 Pharmacokinetics alterations in two critically ill patients on extracorporeal membrane oxygenation receiving isavuconazol

4CPS-163 Early experiences in switching between monoclonal antibodies in chronic migraine preventive therapy

5PSQ-080 Ertapenem-induced neurotoxicity: role of plasma concentration monitoring

5PSQ-070 Pharmaceutical care in an onco-haematological clinical trials unit

4CPS-249 Relationship between renal function and ertapenem plasma concentration in adult patients

5PSQ-012 Drug interactions and polypharmacy in a cohort of HIV positive haemophiliac patients

4CPS-038 Intrapleural colistin for pleural empyema caused by extensively drug-resistant Pseudomonas aeruginosa: a case report

PS-031 Pharmaceutical interventions performed in a short stay emergency service

4CPS-152 Characterisation of a compounded voriconazole solution for nebulisation and description of its use in the clinical setting

6ER-021 Evaluation of COVID mortality during hospital admission in patients receiving oncological treatment

PS-055 BENZODIAZEPINES and Z-DRUGS deprescription by a multidisciplinary pharmacotherapy revision focused on the patient

5PSQ-124 The role of the clinical pharmacist in avoiding medication errors in a clinical research onco-haematologic unit

5PSQ-071 Real-world results of effectiveness and security of erenumab and galcanezumab in migraine patients

4CPS-062 Rituximab pharmacokinetics characterisation in plasma and urine in a patient with nephotic syndrome

4CPS-126 A population pharmacokinetic model of adalimumab in a cohort of paediatric patients with inflammatory bowel disease: a preliminary analysis

4CPS-362 Nonagenarians versus non-nonagenarians in the hip fracture patient: from a pharmacotherapeutic point of view

4CPS-322 Adalimumab concentrations prior to the implementation of therapeutic drug monitoring in patients with inflammatory bowel disease

CP-182 Pharmaceutical validation of treatments: From the pharmacy or at the hospital wards?

5PSQ-080 Identification of pharmacological interactions between ivacaftor/tezacaftor/elexacaftor and dietary supplements/herbs in patients with cystic fibrosis in an outpatient pharmaceutical care unit

5PSQ-095 Comparison between the maximum recommended dose of azathioprine according to the enzymatic activity of thiopurine methyltransferase and 6-thioguanine levels with the maximum tolerated dose

4CPS-131 Ruxolitinib as salvage therapy in paediatric patients with steroid-refractory graft-versus-host disease

NP-012 Standardisation of analgesia and sedation infusion solutions in paediatric palliative patients receiving end-of-life care at home

Efectividad del uso de cefuroxima intracameral como profilaxis en la cirugía de cataratas

Suchergebnisse filtern